DexCom to Present at Oppenheimer 25th Annual Healthcare Conference
December 03 2014 - 8:30AM
Business Wire
DexCom, Inc. (NASDAQ:DXCM) today announced that Steve Pacelli,
Executive Vice President of Strategy and Corporate Development,
will present an update on the company at the Oppenheimer 25th
Annual Healthcare Conference in New York, New York on Wednesday,
December 10, 2014 at 10:55am (EST). The presentation, which will
occur live at the Crowne Plaza Hotel, will be concurrently
webcast.
The link to the webcast will be available on the DexCom website
at www.dexcom.com by navigating to “Our Company,” then “Investor
Relations,” and then “Events and Webcasts” and will be archived
there for future reference.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is
developing and marketing continuous glucose monitoring systems for
ambulatory use by patients and by healthcare providers in the
hospital.
Cautionary Statement Regarding Forward Looking
Statements
DexCom is a medical device company with a limited operating
history. Successful commercialization of the company's products is
subject to numerous risks and uncertainties, including a lack of
acceptance in the marketplace by physicians and patients, the
inability to manufacture products in commercial quantities at an
acceptable cost, possible delays in the company's development
programs, the inability of patients to receive reimbursement from
third-party payors and inadequate financial and other resources.
Certain of these risks and uncertainties, in addition to other
risks, are more fully described in the company's quarterly report
on Form 10-Q for the quarter ended September 30, 2014, as filed
with the Securities and Exchange Commission on November 6,
2014.
DexCom, Inc.Steven R. PacelliExecutive Vice President,
Strategy and Corporate Development(858) 200-0200
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Apr 2024 to May 2024
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From May 2023 to May 2024